[ad_1]
Pfizer shares hit an all-time high on Tuesday, for the first time in more than 20 years, as shares of COVID-19 vaccine makers surged amid rising coronavirus cases in the United States.
Pfizer stock rose in the last session 4.9% to $ 48.25, and hit $ 48.57 during the session. It was also the biggest one-day gain in the action since November 9, when Pfizer released positive data on its COVID-19 vaccine.
“I think they finally got the credit for the vaccine,” said Jeff Jonas, portfolio manager at Gabelli Funds.
While investors previously estimated the impact of the vaccine on the company’s business in the form of a one-time cash injection, recent measurements indicate that the vaccine will be a sustainable business, according to Jonas, adding that Pfizer should be able to take advantage of vaccine technology. for use against cash. Other diseases too, according to Reuters.
Pfizer’s gains come at a time when Moderna shares were down 4% yesterday, but are up about 78% since mid-July, when S&P Dow Jones Indices announced it was adding shares. of the biotechnology company to the benchmark S&P 500.
U.S.-traded shares of Pfizer’s vaccine partner Germany’s Piontech fell more than 5% on Tuesday, but jumped about 30% this month.
Actions by Novavax, which last week delayed its COVID-19 vaccination schedule, also increased by 11%.
It comes after the rapid spread of the delta variant of the coronavirus pushed the number of cases and hospitalizations to its highest level in six months.
Source link
